Adele Boskey, Ph.D., Honored With Symposium on Bone Disease Research

New York—April 25, 2013 

Hospital for Special Surgery (HSS) will honor biomineralization and osteoporosis investigator Adele Boskey, Ph.D., at a symposium on the latest research in bone mineralization and its role in bone disease on Thursday, May 2. Dr. Boskey, Starr Chair in Mineralized Tissue Research, has investigated bone chemistry at HSS since 1970.

Adele Boskey, PhD, honored with a symposium on bone mineralization research

Osteoporosis and other bone diseases affect millions of Americans and the consequences can be devastating. An understanding of the underlying mechanism of these conditions is critical to developing new and better diagnostic tools and treatments. Bone mineralization is one of the most important areas in bone disease research today, and Dr. Boskey is a pioneer in the field.

The event, titled “The Adele Boskey, Ph.D., Symposium on Mineralized Tissues,” will take place at the Richard Menschel Conference Center at Hospital for Special Surgery, starting at 2 p.m. A number of distinguished scientists will discuss their work, and a reception to honor Dr. Boskey will follow the presentations. The event is part of the hospital’s 150th Anniversary celebration programming.

“This is an opportune time to pay tribute to Dr. Boskey for her 40-year career, for her original thinking and seminal research, and for her influence as a mentor to young investigators,” said Steven R. Goldring, M.D., chief scientific officer at HSS.

After a welcome by HSS leaders Thomas P. Sculco, M.D., surgeon-on-chief; Louis A. Shapiro, president and CEO; and Dr. Goldring, Dr. Boskey will begin the symposium with a discussion on bone mineral, explaining what it is and why investigators study it. The program will also feature a group of leading investigators whom Dr. Boskey has mentored. They come from the National Institutes of Health, Boston Children’s Hospital, Cornell University, the University of Michigan and Virginia Commonwealth University. Among the other topics to be explored:

  • Genetic Disorders of Bone Formation and Homeostasis
  • The Role of the Cell in the Mineralization Process
  • Genetic Control of Mineralization
  • Collagen as a Determinant of Bone Properties

“Biology will become more important in the study and treatment of orthopedic diseases in the future,” Dr. Boskey predicts. “In the area of osteoarthritis, for example, I foresee less of an emphasis on metal and devices and more on understanding the biology that leads to the need for a total joint replacement in the first place.”

Dr. Boskey is director of the Mineralized Tissue Laboratory and program director of the Musculoskeletal Integrity Program at HSS. In 2010, she received the Orthopaedic Research Society/American Orthopaedic Association Alfred R. Shands, Jr. Award, which honors a scientist who has made significant contributions to the understanding of musculoskeletal disease.

As the first female president of the Orthopaedic Research Society, her mentoring of other women researchers was recognized in 2008 with an award from the Orthopaedic Research Society Women’s Leadership Forum.

Dr. Boskey’s current research focuses on bone quality, a measurement of both the bone matrix and the mineral of bone. The current measure used to identify osteoporosis and the risk for a fracture is bone density, but she believes that measuring bone quality promises greater accuracy and could significantly decrease the number of patients at risk for fracture.

To better define bone quality, Dr. Boskey has repurposed the use of infrared spectroscopy to approach the quality of bone when biopsies are available. Her laboratory, the Musculoskeletal Repair and Regeneration Core Center at HSS, is using this technology to understand how mineral size and content are related to osteoporosis and fracture risk.

Osteoporosis causes more than 1.5 million fractures annually. Dr. Boskey hopes her research will lead to a decrease in that number by gaining a better understanding of the biology and makeup of the bone itself and by analyzing the effects of commonly used osteoporosis medications on bone quality.

View a complete list of symposium topics and speakers.

About Hospital for Special Surgery
Founded in 1863, Hospital for Special Surgery (HSS) is a world leader in orthopedics, rheumatology and rehabilitation. HSS is nationally ranked No. 1 in orthopedics, No. 3 in rheumatology, No. 10 in neurology, and No. 5 in geriatrics by U.S.News & World Report (2012-13), and is the first hospital in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center three consecutive times. HSS has one of the lowest infection rates in the country. From 2007 to 2011, HSS has been a recipient of the HealthGrades Joint Replacement Excellence Award. HSS is a member of the NewYork-Presbyterian Healthcare System and an affiliate of Weill Cornell Medical College and as such all Hospital for Special Surgery medical staff are faculty of Weill Cornell. The hospital's research division is internationally recognized as a leader in the investigation of musculoskeletal and autoimmune diseases. Hospital for Special Surgery is located in New York City and online at www.hss.edu.
^ Back to Top
Request an Appointment